FDA 执法报告 D-0076-2027:Hikma 阿比特龙醋酸酯片批号 3047 因重量均匀度不合格列为 II 类召回
FDA drug enforcement D-0076-2027: Hikma Pharmaceuticals USA INC. — Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
openFDA 执法报告 D-0076-2027 显示,Hikma Pharmaceuticals USA 发起的阿比特龙醋酸酯(Abirtega)USP 250 mg 片剂召回被列为 II 类,原因是重量均匀度不符合片剂标准。
记录列出了阿比特龙醋酸酯片重量均匀度不合格召回的类别、批号与分销范围,便于核对批次追溯信息。
FDA drug recall enforcement report — D-0076-2027
Report issued: 2026-10-28. This is the enforcement report date, not the recall initiation date.
Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.
The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.
Complete official product record (including openFDA harmonized identifiers):
{
"address_1": "1809 Wilson Rd",
"address_2": "",
"center_classification_date": "20261023",
"city": "Columbus",
"classification": "Class II",
"code_info": "Lot #: 3047, Exp Date July 2027.",
"country": "United States",
"distribution_pattern": "Nationwide within the United States",
"event_id": "100046",
"initial_firm_notification": "Letter",
"more_code_info": "",
"openfda": {
"application_number": [
"ANDA208339"
],
"brand_name": [
"ABIRTEGA"
],
"generic_name": [
"ABIRATERONE ACETATE"
],
"is_original_packager": [
true
],
"manufacturer_name": [
"CivicaScript, LLC"
],
"package_ndc": [
"82249-011-12"
],
"product_ndc": [
"82249-011"
],
"product_type": [
"HUMAN PRESCRIPTION DRUG"
],
"route": [
"ORAL"
],
"rxcui": [
"1100075",
"2702601"
],
"spl_id": [
"692d596d-5465-4611-82f7-5d50c37270a2"
],
"spl_set_id": [
"2f932015-28b2-4f44-ac04-772e982e13e9"
],
"substance_name": [
"ABIRATERONE ACETATE"
],
"unii": [
"EM5OCB9YJ6"
],
"upc": [
"0382249011123"
]
},
"postal_code": "43228-9579",
"product_description": "Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12.",
"product_quantity": "2136 bottles",
"product_type": "Drugs",
"reason_for_recall": "Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.",
"recall_initiation_date": "20261006",
"recall_number": "D-0076-2027",
"recalling_firm": "Hikma Pharmaceuticals USA INC.",
"report_date": "20261028",
"state": "OH",
"status": "Ongoing",
"voluntary_mandated": "Voluntary: Firm initiated"
}
来源:openFDA 已分级药品召回执法报告 · api.fda.gov